Skip to main content

Table 5 Percentage of 3-year survival in randomized trials in comparison to the present study

From: Routine management of locally advanced cervical cancer with concurrent radiation and cisplatin. Five-year results

Study

N patients

IB2%

IIB%

IIIB%

IVA%

OS

GOG123

183

100

0

0

0

83

GOG85

177

0

61

33.9

2.8

67

RTOG9001

195

32

36

27

3

75

GOG120

177/173

0

51.8

42.4

2.6

65

THIS

294

23.2*

53.2

20.4**

0.7

76.5

  1. *23.2% includes IB bulky and IIA; **20.4% includes 2.3% cases of IIIA. GOG85 and GOG120 had highest proportions of IIB and IIIB.
Back to article page

BMC Women's Health

ISSN: 1472-6874

Contact us